These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34908399)

  • 1. Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents.
    Yang Y; Xu Y; Yue Y; Wang H; Cui Y; Pan M; Zhang X; Zhang L; Li H; Xu M; Tang Y; Chen S
    ACS Chem Biol; 2022 Jan; 17(1):39-53. PubMed ID: 34908399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and antibacterial activity of derivatives of Tryptophanyl-tRNA synthetase inhibitor indolmycin.
    Sun L; Zhang S; Kou S; Yi H; Cui A; Li Z
    Eur J Med Chem; 2022 Nov; 241():114647. PubMed ID: 35963132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Inhibition of Bacterial Tryptophanyl-tRNA Synthetases by Indolmycin Is Mechanism-based.
    Williams TL; Yin YW; Carter CW
    J Biol Chem; 2016 Jan; 291(1):255-65. PubMed ID: 26555258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolmycin resistance of Streptomyces coelicolor A3(2) by induced expression of one of its two tryptophanyl-tRNA synthetases.
    Kitabatake M; Ali K; Demain A; Sakamoto K; Yokoyama S; Söll D
    J Biol Chem; 2002 Jun; 277(26):23882-7. PubMed ID: 11970956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tryptophanyl-tRNA synthetase gene confers high-level resistance to indolmycin.
    Vecchione JJ; Sello JK
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3972-80. PubMed ID: 19546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
    Guzman JD; Gupta A; Evangelopoulos D; Basavannacharya C; Pabon LC; Plazas EA; Muñoz DR; Delgado WA; Cuca LE; Ribon W; Gibbons S; Bhakta S
    J Antimicrob Chemother; 2010 Oct; 65(10):2101-7. PubMed ID: 20719764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.
    Gurcha SS; Usha V; Cox JA; Fütterer K; Abrahams KA; Bhatt A; Alderwick LJ; Reynolds RC; Loman NJ; Nataraj V; Alemparte C; Barros D; Lloyd AJ; Ballell L; Hobrath JV; Besra GS
    PLoS One; 2014; 9(11):e113568. PubMed ID: 25409504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.
    Li H; Cowie A; Johnson JA; Webster D; Martyniuk CJ; Gray CA
    BMC Genomics; 2016 Aug; 17(1):621. PubMed ID: 27514659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
    Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of indolyl-containing peptides as novel antibacterial agents targeting tryptophanyl-tRNA synthetase.
    Zhang S; Qiu X; Wang R; Sun L; Zhu Z; Shan G; Li Z
    Future Med Chem; 2020 May; 12(10):877-896. PubMed ID: 32312096
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in
    Negatu DA; Yamada Y; Xi Y; Go ML; Zimmerman M; Ganapathy U; Dartois V; Gengenbacher M; Dick T
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria.
    McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN
    Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an inducible, antibiotic-resistant aminoacyl-tRNA synthetase gene in Streptomyces coelicolor.
    Vecchione JJ; Sello JK
    J Bacteriol; 2008 Sep; 190(18):6253-7. PubMed ID: 18621902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.
    Retailleau P; Huang X; Yin Y; Hu M; Weinreb V; Vachette P; Vonrhein C; Bricogne G; Roversi P; Ilyin V; Carter CW
    J Mol Biol; 2003 Jan; 325(1):39-63. PubMed ID: 12473451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
    Claes P; Cappoen D; Mbala BM; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
    Eur J Med Chem; 2013 Sep; 67():98-110. PubMed ID: 23850570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of apicoplast tryptophanyl-tRNA synthetase causes delayed death in Plasmodium falciparum.
    Pasaje CF; Cheung V; Kennedy K; Lim EE; Baell JB; Griffin MD; Ralph SA
    Sci Rep; 2016 Jun; 6():27531. PubMed ID: 27277538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide deformylase inhibitors as potent antimycobacterial agents.
    Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.